Hepatitis C virus (HCV) core protein forms the internal viral coat that encapsidates the genomic RNA and is enveloped in a host cell-derived lipid membrane. As the single capsid protein, core should be capable of multimerization but attempts to produce virus-like particles following expression of HCV structural proteins have not been successful. In this study, we have analysed the interaction capacity of full-length and truncated HCV core using the yeast two-hybrid system. Full-length core containing or lacking the translocation signal for the E1 glycoprotein did not interact with full-length or truncated core proteins. Truncation to the N-terminal 122 aa revealed an interaction domain which was mapped to the tryptophan-rich sequence from aa 82-102 and was termed the main homotypic interaction domain. The C-terminal hydrophobic
Introduction
Hepatitis C virus (HCV) is a positive-stranded RNA virus belonging to the family Flaviviridae (Francki et al., 1991) . It is the major aetiological agent of post-transfusion non-A, non-B hepatitis (Choo et al., 1989 ; Kuo et al., 1989) and usually causes persistent infection, resulting in chronic hepatitis, liver cirrhosis, hepatocellular carcinoma and some extrahepatic disorders (reviewed by Houghton, 1996) . Although the epidemiology and pathology of HCV infection have been well characterized, the virus itself has remained rather elusive. No infectious clone of HCV and no efficiently permissive cell line are available. Furthermore, HCV therapy is limited to the use of interferon (which is beneficial only in a subset of patients and causes considerable adverse effects). In addition, no subAuthor for correspondence : Hans-Georg Kra$ usslich.
Fax j49 40 48051 184. e-mail hgk!hpi.uni-hamburg.de † Permanent address : Influenza Institute, St Petersburg, Russia. fragment of core (aa 122-172) was incapable of interacting with itself but interacted with the main homotypic interaction domain in trans (the weak heterotypic interaction domain). Core proteins truncated at their N and C termini (aa 46-102) were trans-activating when fused to the DNA-binding domain of GAL4. Based on our results, we suggest that the C-terminal segment may interact in cis with the main homotypic interaction domain and thereby prevent multimerization. Core-core interaction was also observed for in vitro-translated proteins bound to truncated immobilized core102. However, interaction was less specific in this system suggesting that protein interaction and possibly conformational alteration of core may be dependent on the experimental system. genomic expression systems for studying virus replication and\or assembly have been developed therefore restricting analysis to the biochemical properties of individual viral proteins.
The HCV genome is a single-stranded RNA of positive polarity which encodes a long polyprotein of about 3010 residues (Choo et al., 1991) . Expression of the polyprotein is controlled by an internal ribosomal entry site (IRES) for capindependent translation (Tsukiyama-Kohara et al., 1992 ; Lu & Wimmer, 1996) . The putative structural proteins, core (C) and the glycoproteins (E1 and E2), are located in the N-terminal quarter of the polyprotein, followed by the nonstructural proteins NS2, NS3, NS4a, NS4b, NS5a and NS5b (Harada et al., 1991 ; Hijikata et al., 1991 ; Grakoui et al., 1993) . Host cell signal peptidase and two viral proteinases cleave the polyprotein to its final components (Hijikata et al., 1991 ; Grakoui et al., 1993 ; Bartenschlager et al., 1993) . The core protein, which is derived from the N terminus of the polyprotein, most likely forms the viral nucleocapsid because of its similar position within the 0001-4403 # 1997 SGM BDDB genome of related viruses. Moreover, HCV core is a highly basic protein and shows homology to nucleocapsid proteins of other flaviviruses (Takeuchi et al., 1990 ; Harada et al., 1991 ; Grakoui et al., 1993 ; reviewed by Rice, 1996) . Recent studies have demonstrated that HCV core can be phosphorylated in vitro by phosphokinases A and C (Shih et al., 1995) and that it binds RNA nonspecifically in vitro (Santolini et al., 1994) . The nucleotide and predicted amino acid sequence of core is well conserved among different HCV isolates (Bukh et al., 1994) . There are two hydrophobic segments in the C-terminal half of the protein : one (approximately aa ) is considered to correspond to the signal sequence for translocation of E1 into the endoplasmic reticulum (ER) ; the second (aa 121-151 ; Takamizawa et al., 1991 ; Bukh et al., 1994) may be involved in membrane binding (Santolini et al., 1994) . HCV core including the E1 translocation signal contains 191 aa and a protein of approximately 21 kDa (p21) has been detected following in vitro translation or expression in transfected cells (Harada et al., 1991 ; Hijikata et al., 1991) . More recent data (Santolini et al., 1994 ; Lo et al., 1994 Lo et al., , 1995 Moradpuor et al., 1996) indicate that core protein is converted to a shorter product in the presence of microsomal membranes, probably reflecting removal of the ' signal peptide ' by cellular membrane associated proteases. This cleavage maps to approximately aa 172 (Santolini et al., 1994) . A third HCV core protein of approximately 16 kDa (p16) was identified in a variant of core containing an amino acid substitution from arginine to lysine at position 9 (Lo et al., 1994) . In addition, a 26 kDa C-specific antigen was detected in HCV nucleocapsids partially purified from pooled human plasma (Takahashi et al., 1992) .
Expression of full-length core in mammalian cells either alone or as a fusion with E1 and E2 leads to cytoplasmic localization of the protein when examined early (i.e. 2-3 days) after transfection with a reticular staining pattern most likely reflecting association with membranes of the ER (Santolini et al., 1994 ; Moradpuor et al., 1996 ; O. Nolandt & H.-G. Kra$ usslich, unpublished observation) . At later time-points (6 days after transfection) HCV core was also detected in the nuclei of transfected cells. Expression of C-terminally truncated core proteins either alone or as a fusion with β-galactosidase resulted in nuclear proteins early after transfection and three independent nuclear localization signals have been described (Shih et al., 1993 ; Chang et al., 1994 ; Suzuki et al., 1995 ; Lo et al., 1995) . HCV core protein has been shown to suppress hepatitis B virus (HBV) gene expression and phosphorylation is essential for this activity (Shih et al., 1993 (Shih et al., , 1995 . In addition, HCV core protein modulates transcription from several cellular and viral promotors (Ray et al., 1995) . These results suggest that HCV core may have additional functions in virus replication and pathogenesis besides being the viral coat protein.
Recently, immunoelectron microscopy studies performed on HCV particles recovered from the circulation of an infected host (Abe et al., 1989 ; Takahashi et al., 1992 ; Kaito et al., 1994 ; Li et al., 1995) , on liver tissue (Li et al., 1995 ; Shimizu et al., 1996) , on in vitro infected cells (Shimizu et al., 1996) and on cells infected with a vaccinia virus vector expressing the complete HCV genome (Mizuno et al., 1995) have indicated the presence of virus-like particles ranging from 36 to 65 nm in diameter. However, we and others (Moradpour et al., 1996) failed to detect such virus-like structures upon expression of either core alone or together with glycoproteins E1 and E2 or longer segments of the polyprotein. As the viral coat protein, HCV core should be able to interact with itself and to multimerize. Recent studies have shown that coat proteins of many viruses are capable to oligomerize in vitro. Interaction of human immunodeficiency virus (HIV) and hepatitis B virus (HBV) structural proteins has been demonstrated using the yeast two-hybrid system (Fields & Song, 1989) and potential interaction domains have been mapped (Luban et al., 1992) . We have used the two-hybrid system to map interaction domains in the HCV core protein which may be important for virus assembly and other biological activities. Here, we report that full-length core protein with or without the membrane translocation sequence of E1 did not show homotypic interaction in yeast and did not interact with truncated core proteins. C-terminal truncation revealed an interaction domain which was mapped to aa 82-102. Truncated core proteins also interacted with a C-terminal fragment of core which did not show homotypic interaction. These results suggest that a core interaction domain is present in the central region of HCV core which can be masked in the full-length protein by a C-terminal interacting domain, at least in the yeast two-hybrid system. While this work was in progress, Matsumoto et al. (1996) reported a less extensive two-hybrid screen which also indicated that the protein interaction domain resides in the first 115 aa of HCV core.
Methods
Plasmid construction. A segment of the cDNA (nt 14-1365) of the German HCV isolate HD1 (Mueller et al., 1993 ; genotype Ib) was cloned into pBluescript KS(j) (Stratagene) generating pBHCV1365. A NcoI site was introduced at the beginning of the HCV open reading frame (nt 340-345) by altering the sequence from CCATGA to CCATGG, to give pB-N-HCV1365. Different fragments of the HCV core gene were cloned into yeast shuttle vectors downstream of either the binding (pGBT9) or the activation (pGAD424) domain of GAL4 (Matchmaker two-hybrid system, Clontech ; see Fig. 1 ). The NcoI-FspI fragment from pB-N-HCV1365 (codons 1-194 of the polyprotein ; C1) was treated with Klenow enzyme and cloned into the SmaI sites of pGAD424 and pGBT9 (Chien et al., 1991) , generating an NcoI site in the cloning region of these vectors. A PCR fragment encoding C-terminally truncated HCV core (codons 1-172 ; C2) was generated using pB-N-HCV1365 as template and primers 5h GGACGACCGGGTCCTTTCTTGG 3h (position 180-201) and 5h GCGAATTCGGATCCTATCAGCAACCGGGTAGATT-CCCTGT 3h (reverse position 837-857). The reverse primer introduced new BamHI and EcoRI sites at the 3h end of the HCV coding region. The PCR product was digested with NcoI and BamHI and cloned into the shuttle vectors pGAD424 and pGBT9 to give plasmids pGAD-C2 and pGBT-C2. The other constructs (C3, C5, C6) were created by cleaving pGAD-C2 or pGBT-C2 with NarI, SacII and KpnI, respectively and with BamHI followed by treatment with Klenow enzyme and religation. Because no interaction between different core fusions was detected (data not shown), a second generation of shuttle vectors (pACTII and pAS2 ; Clontech) was used, which give higher expression of fusion protein (Dufee et al., 1993) . HCV core fragments were excised from pGBT9 by NcoI\BamHI digestion and recloned into pAS2 and pACTII cut with the same enzymes (C1, C2, C3, C6). The fragment containing HCV core codons 1-102 (C5) was excised from pGBT-C5 using NcoI\SalI and inserted into pACTII, cleaved with the same enzymes. For cloning into pAS2, pGBT-C5 was cleaved with SalI, treated with Klenow enzyme and recut with NcoI. This fragment was inserted into pAS2 cut with NcoI\SmaI. The constructs C4, C7, C8 were generated from pAS-C1 by digestion with ClaI, StyI and BssHII, respectively, and treatment with Klenow enzyme. The fragments were excised using NcoI and cloned into pACTII cut with NcoI\SmaI. They were recloned into pAS2 using NcoI and BamHI. The internal deletion mutant removing codons 82-122 of HCV core (C9) was generated by cleaving pAS-C1 with KpnI, treatment with T4 polymerase and ClaI digestion, followed by Klenow enzyme treatment and religation. The internal deletion mutant removing codons 102-122 (C10, C11) was made by cleaving pAS-C1 with SacII and ClaI, treatment with Mung Bean nuclease and religation. All three fragments (C9, C10, C11) were recloned into pACTII using NcoI and BamHI. The N-terminal truncation of core (C12) was made by cleaving pAS-C1 with ClaI followed by treatment with Klenow enzyme. The fragment was excised using BamHI and recloned into pAS2 and pACTII opened with SmaI\BamHI. The C-terminally truncated version of C12 (C13) was made by cloning the NarI\BamHI fragment of pAS-C2 into pACT-C12 cleaved with the same enzymes. The C14 and C15 HCV core fragments in pAS2 and pACTII were made by digestion of pAS-C5 and pACT-C5 with NcoI and BssHII or NcoI and KpnI followed by treatment with Klenow enzyme and religation. The C16 HCV core fragment was made from pAS-C1 and pACT-C1 by digestion with ClaI, treatment with Klenow enzyme and religation. All fusion and deletion procedures were confirmed by nucleotide sequencing.
Yeast two-hybrid system. Saccharomyces cerevisiae strain SFY526 (Bartel et al., 1993) was grown in YPD (1 % yeast extract, 2 % peptone, 2 % dextrose). Yeast cells were transformed using the lithium acetate method as recommended by the manufacturer (Clontech). Cells were plated on synthetic media lacking leucine and tryptophan to select for both shuttle vectors. Reporter gene activity was estimated in filter assays (white\blue selection) and quantified in a liquid β-galactosidase (β-gal) assay using onitrophenyl β--galactopyranoside (ONPG) as a substrate. For the filter assay, transformed yeast colonies were lifted onto nitrocellulose filters, lysed by freezing for 10 s in liquid nitrogen, and stained in situ with X-Gal for 1-6 days at room temperature as recommended by the manufacturer. For the liquid assay, yeast cells were pelleted and lysed by freezing in liquid nitrogen and rapid thawing at 37 mC. Buffer Z (200 µl : 0n1 M sodium phosphate, pH 7n0, 1 mM MgSO % , 10 mM KCl) containing 2-mercaptoethanol (0n3 %) and ONPG (2 mg\ml) was added and the reaction was allowed to proceed at room temperature for 12-24 h. The absorbance was measured at 405 nm after pelleting the yeast debris. The core protein of hepatitis B virus, cloned into pGAD424 and pGBT9 shuttle vectors (kindly provided by M. Nassal, Heidelberg, Germany) was used as a positive control for protein-protein interactions. Negative controls were performed as suggested by the manufacturer.
Bacterial expression and purification of HCV core102 (C5). The DNA fragment encoding core102 (C5) was excised from pAS-C5 using NdeI and BamHI and cloned into pET16 (Novagen) digested with the same enzymes to give pET16-C5. This plasmid encodes the core coding sequence with a polyhistidine tag fused to its N terminus. Freshly transformed Escherichia coli BL21(DE3) was grown to an OD '!! of 0n8 and induced by addition of 1 mM IPTG. Cells were harvested 4 h after induction, disrupted in buffer A (6 M guanidinium hydrochloride, 0n1 M sodium phosphate, 10 mM Tris-HCl, pH 8n0) by sonication and cleared lysates were loaded onto an Ni-NTA column (Qiagen) equilibrated with buffer A. After extensive washing with buffer A, buffer B (8 M urea, 0n1 M sodium phosphate, 10 mM Tris-HCl, pH 8n0) and buffer C (8 M urea, 0n1 M sodium phosphate, 10 mM Tris-HCl, pH 6n3), the histidinetagged protein was eluted with buffer D (8 M urea, 0n1 M sodium phosphate, 10 mM Tris-HCl, pH 5n9). Fractions containing the core102 protein were pooled and dialysed against binding buffer (50 mM NaCl, 50 mM Tris-HCl, pH 7n5, 1 mM DTT).
In vitro translation of HCV core proteins. HCV-specific fragments from plasmids pAS-C1, -C2, -C3, -C5 and -C9 were excised with NcoI and BamHI and cloned into the vector pBR-EPR (H.-G. Kra$ usslich, unpublished data) which had been cut with the same enzymes. This plasmid is a derivative of pBR328 containing the bacteriophage T7 promotor followed by the encephalomyocarditis virus (EMCV) IRES for cap-independent enhanced translation. For cloning, a naturally occurring NcoI site in codon 6 of the EMCV leader peptide was used. In vitro translation was performed in a coupled transcription-translation system (TT, Promega) using 25 µg\ml plasmid DNA linearized with SpeI in the presence of [$&S]Met\Cys (1000 Ci\mol, Amersham) as recommended by the manufacturer.
In vitro binding assay. For in vitro binding, 10 µg of purified, histidine-tagged HCV core102 was bound to 100 µl Ni-NTA beads in binding buffer containing 8 M urea and washed extensively with binding buffer without urea. As control protein, we used histidine-tagged human T-lymphotropic virus type I (HTLV-I) proteinase (PR ; kindly provided by T. Khalid & B. Mu$ ller) immobilized to the Ni-NTA resin by the same method. Subsequently, 10 µl radioactively labelled translation mixture was diluted to 200 µl in binding buffer and incubated with immobilized core102 or immobilized HTLV-1 PR overnight at 4 mC and constant agitation. Beads were collected by brief centrifugation, washed five times with binding buffer containing 0n1 % Triton X-100 and once with 150 mM NaCl, 50 mM Tris-HCl, pH 7n5. Bound proteins were released by boiling in sample buffer and separated on a 17n5 % SDSpolyacrylamide gel followed by detection of labelled proteins by autoradiography.
Immunoblot detection. For Western blot analysis, yeast cells were pelleted from liquid culture, resuspended in yeast loading buffer (125 mM Tris-HCl, pH 6n8, 20 % glycerol, 10 % 2-mercaptoethanol, 4 % SDS) and boiled for 10 min. After centrifugation, the supernatant was analysed on 17n5 % SDS-polyacrylamide gels followed by transfer to nitrocellulose membranes. HCV fusion proteins were detected by incubation with serum from an HCV-positive human (dilution 1 : 100) followed by alkaline phosphatase-conjugated rabbit anti-human serum (dilution 1 : 2500) and colour development.
Results

Truncation of HCV core reveals a homotypic interaction domain which is masked in the full-length protein
To analyse core multimerization and define potential interaction domains, N-and C-terminal truncations and internal deletions were constructed in the coding region of core (Fig. 1) . All constructs were made as fusions with the DNA-binding Fig. 1 . Schematic representation of HCV core protein coding regions inserted into GAL4-AD and GAL4-BD vectors to analyse core-core interaction in the yeast two-hybrid system. The core region in the HCV genome is shown in the upper part. Underneath, the core region is expanded and cleavage sites for various restriction endonucleases used in the cloning procedure are indicated. In the lower part, the different truncated and internally deleted core regions are schematically depicted. Plus-1 reading frame indicates that a frameshift mutation was introduced by the cloning procedure and translation continues in a different reading frame. Vertical arrows indicate the position of naturally occurring stop codons in the plus-1 reading frame. Amino acid numbers at the site of truncation are indicated on the right. The abbreviated name for each construct (C1-C16) is indicated on the left. All constructs were made in the GAL4-BD (pAS2) vector and in the GAL4-AD (pACTII) vector. The HCV-specific region from construct C5 was also recloned into a bacterial expression vector. The HCV-specific regions from constructs C1, C2, C3, C5 and C9 were recloned into in vitro translation vectors.
domain and with the activation domain of the GAL4 yeast trans-activator to allow testing of all possible combinations. Initially, experiments were performed using first generation yeast two-hybrid vectors. However, no interaction was observed for HCV-specific constructs although blue colonies were detected in the controls, including GAL4-fusions with the core protein of HBV (data not shown). Therefore, all constructs were recloned into two-hybrid vectors (pAS2 and pACTII) which give significantly higher expression of fusion proteins (Legrain et al., 1994) . Plasmids C1 encode full-length core including the signal sequence for translocation of E1 and the first three amino acids of E1 (Fig. 1) . Constructs C2-C8 encode serial C-terminal truncations of core which successively remove the putative signal peptide of E1 (C2), all or part of the second hydrophobic region (C3, C4), and parts of a tryptophan-rich region (C5, C6). The shortest fusion proteins retained only the first 65 (C7) and 46 (C8) amino acids of core, respectively.
All possible combinations of plasmids were transfected into yeast and colonies were analysed for β-gal activity. Since initial experiments did not yield enzyme activity, we investigated whether fusion proteins were synthesized and stably maintained. Yeast cells expressing binding domain fusions of HCV core were analysed by immunoblot using antiserum from an HCV-positive individual. As shown in Fig. 2 , a specific signal was observed in all cases, albeit with variable intensity. No HCV-specific signal was observed in yeast cells expressing the GAL4 DNA-binding domain alone (Fig. 3, lane 9) . The fusion proteins showed the expected electrophoretic mobilities ranging from 31 kDa (C5) to 42 kDa (C1). The relative expression level of the various fusion proteins did not correlate with their capacity to mediate trans-activation in the twohybrid system (see below).
Interaction of core protein fusions in the yeast two-hybrid system is shown in Fig. 3 . Full-length core194 (C1) did not interact with either full-length or any of the truncated core proteins. Lack of interaction was not caused by the C-terminal membrane anchor since removal of the last 20 amino acids of core (C2) did not alter the result. Further deletion to 141 amino acids yielded weak interaction in the two-hybrid system. Much stronger interaction was observed when core was truncated to 102 amino acids (C5). Further truncation to 82 amino acids (C6) led to considerably reduced interaction and truncation to 65 amino acids or beyond (C7 and C8) caused complete loss of interaction. To validate these results β-gal activity was also determined in a liquid assay. These experiments showed that core fusions C1 and C2 reduced the level of activity below the background level of unfused shuttle vectors. Significant β-gal activity was observed for constructs C4 and C5 while (in Fig. 3 . Mapping of putative interaction domains in the HCV core protein using the yeast two-hybrid system. Yeast cells were transformed with BD-and AD-fusion constructs as indicated and β-gal activity was estimated in a filter assay as described in Methods. Open boxes indicate white colonies or no detectable interaction. Grey boxes and shaded boxes represent intermediately blue colonies while filled boxes represent dark-blue colonies. Each combination of vectors was tested at least twice and 10 colonies were judged to determine the relative interaction. This figure depicts only one of the two possible combinations for each two fusion constructs (i.e. BD-C1 with AD-C8 but not BD-C8 with AD-C1). The second possible combination was also experimentally tested and gave identical results (except in the case of C14 and C15 which showed trans-activating potential by themselves only when fused with GAL4-BD). This second set of experiments is omitted from the figure for reasons of clarity. Yeast expression vectors only containing GAL4-AD or -BD but no HCV-specific inserts (denoted ' 0 ') were used as negative controls ; vectors encoding HBV core fused to GAL4-AD and -BD were used as positive controls (data not shown).
contrast to the filter assay) no activity was detected for constructs C3 and C6.
Besides analysis of fusion proteins containing equal length core segments, we performed two-hybrid screens for each possible combination of truncated core fusions. These experiments confirmed that core194 and core172 were incapable of interacting with other core variants while strong interaction was observed when core102 was expressed together with another truncated fusion protein. The results suggested that a main interaction domain is present within the region aa 82-102 of core.
The main interaction domain is required but not sufficient for core interaction and can interact in trans with a C-terminal core fragment
Further deletions within the core coding region were constructed to analyse the relevance of various domains for protein interaction. A central hydrophilic region was deleted in C10 ( Fig. 1) while in C9 most of the tryptophan-rich region was deleted in addition. Constructs C11 and C16 contained frame-shift mutations yielding non-sense heterologous sequences following aa 102 and 122, respectively. In both cases, translation is terminated at a naturally occurring stop codon in the j1 reading frame. Two additional constructs (C12 and C13) contained only the C-terminal tail of core either including or lacking the signal sequence for E1. Finally, constructs were made containing deletions of the N-and Cterminal regions of core (C14 and C15). In these cases, transactivation was observed for fusions with the GAL4 DNAbinding domain, even in the absence of a second plasmid providing the GAL4 activation domain. Thus, fusion proteins encoded by constructs C14 and C15 with the DNA-binding domain have trans-activating potential by themselves and could not be tested. (1, 4, 7, 10, 13, 16) corresponds to the translation reaction without additional binding reaction, the second lane (2, 5, 8, 11, 14, 17) corresponds to material bound to immobilized core102 and the third lane (3, 6, 9, 12, 15, 18) Experiments with fusion proteins encoding internally deleted core variants confirmed that strong interaction was dependent on the absence of the C terminus of core (C10). This inhibitory effect was specific for the core sequence and was not observed for frame-shift mutants containing an unrelated sequence encoded by the j1 reading frame (C11 and C16 ; Fig. 3 ). N-terminally truncated versions of the C5 construct (i.e. C14 and C15) were also incapable of interaction, indicating that the main interaction domain by itself is not sufficient for multimerization (Fig. 3) . Deletion of the main interaction domain within a full-length HCV core fusion protein (C9) revealed weak interaction, although the C-terminal segment of core was retained in this construct. This result indicated that trans-interaction of core in the two-hybrid system depended on the absence of either the C-terminal segment of core or the main interaction domain, suggesting that these two regions may interact in cis thereby abrogating core interaction in trans. Interaction of the main interaction domain with the C-terminal segment of core was indeed observed when core102 and related fusion proteins were expressed together with fusion proteins encoding only the C terminus of core ( Fig. 3 ; e.g. C12 and C13 together with C5). The C-terminal segment of core (aa 122-172) which was incapable of homotypic interaction (e.g. C12 together with C12 ; Fig. 3 ) was therefore termed the weak heterotypic interaction domain to indicate its potential to interact with the central region of core.
Analysis of the in vitro interaction of HCV core proteins
To define core-core interactions in more detail, we performed in vitro translation of core proteins with and without the capacity to interact in the two-hybrid system followed by in vitro binding to immobilized core protein. Since full-length core was not expressed well in bacteria (data not shown) and core102 (C5) showed the highest activity in yeast, this protein was expressed with an N-terminal histidine tag (Fig. 4B , lane 1) and purified using a denaturing protocol. Removal of denaturing agents led to precipitation of approximately half of the protein (Fig. 4B, lane 2) . The remaining soluble fraction (Fig. 4B, lane 3) was subsequently used for immobilization and binding of in vitro translated proteins. It contained three smaller proteins which correspond to C-terminal truncation products of core, likely cleaved by bacterial proteinases. Interestingly, the shorter core proteins were completely soluble while core102 and longer versions were largely insoluble even after purification. Core102 was again denatured before binding to the Ni-NTA resin because binding to (and elution from) the resin only occurred in the presence of denaturing agents (data not shown). Similarly, GST fusion proteins containing core102 and longer versions showed poor binding to glutathioneagarose columns and mostly truncated proteins were obtained after purification (data not shown). These results suggest that fusion with core102 or longer HCV core proteins may induce strong conformational rigidity on the respective fusion proteins thereby making the domains used for purification inaccessible to the ligand.
A selected subset of core proteins which did (C3, C5) or did not (C1, C2, C9) show interaction with core102 (C5) in the yeast genetic screen was subjected to a coupled transcriptiontranslation reaction in vitro (Fig. 4) . Proteins of the expected size were obtained in each case and no specific translation products were observed in the absence of DNA (Fig. 4C) . HCV core proteins translated in vitro (Fig. 4D, lanes 1, 4, 7 , 10, 13 and 16) were incubated with immobilized core102 or a nonspecific histidine-tagged protein (HTLV-I PR). All core proteins analysed, including those that scored negative in the genetic screen, bound to immobilized core102 (lanes 2, 5, 8, 11 and 14) . Binding to the non-specific control protein was also observed, albeit to a significantly lesser extent (lanes 3, 6, 9, 12 and 15). In the upper part a hydrophobicity plot on a Kyte-Doolittle scale from -5 to j5 (with positive numbers corresponding to increased hydrophobicity) with a window size of 6 is shown for the core protein of the HCV isolate HD1 (Mueller et al., 1993) . The amino acid numbers indicate the positions of truncations and deletions described (see Fig. 1 ). The central part depicts a compilation of published features of HCV core proteins. Open boxes describe conserved sequence motifs (Bukh et al., 1994) . Dark boxes describe functions mapped to specific regions in core : three independent nuclear localization signals (NLS) (Chang et al., 1994) ; sequences required for non-specific RNA-and ribosome-binding in vitro (Santolini et al., 1994) ; sequences responsible for trans-repression of HBV gene expression (Shih et al., 1993 (Shih et al., , 1995 ; the signal peptide for E1 which is cleaved from core both in vitro and in vivo (Hijikata et al., 1991 ; Harada et al., 1991 ; Grakoui et al., 1993 ; Lo et al., 1995 , Santolini et al., 1994 . A putative DNA-binding motif (SPRG) located between aa 99-102, a conserved arginine-rich sequence from aa 38-71 and a conserved tryptophan-rich region from aa 73-108 (Bukh et al., 1994) are depicted as open boxes. Core can be phosphorylated on serine residues 53, 99 and 116 in vivo and in vitro (Lanford et al., 1993 ; Shih et al., 1995) . The lower part of the figure shows the two interaction domains in core identified in this study. The main homotypic interaction domain maps to aa 82-102 (dark box) within the conserved tryptophan-rich sequence. The weak heterotypic interaction domain maps to the hydrophobic domain from aa 122-172 (hatched box). All indicated features are drawn to scale.
Binding of in vitro translated core proteins to Ni-NTA resin was observed at similar levels as to immobilized HTLV-I PR (data not shown). Selective washing procedures with increasing salt and detergent concentrations did not reveal significant differences in binding of the various core proteins. Interaction was completely dissociated at a concentration of 0n5 M salt in all cases and was stable to 0n5 % Triton X-100 (data not shown).
In vitro incubation of N-terminally truncated core (C12) revealed binding to immobilized core102 but also to immobilized HTLV-I PR and to the resin without any attached ligand (data not shown). Most likely, this result is due to hydrophobic interaction of the 72 aa hydrophobic C12 peptide (see Fig. 5 ) with the resin.
Discussion
The primary function of a viral nucleocapsid protein is to provide a protective shell for the viral genome in the extracellular phase of the replication cycle. Therefore, viral core proteins should have the ability to oligomerize in vitro and in transfected cells, given that the appropriate environment is provided. Protein interaction domains within viral capsid proteins have been determined in many systems and assembly in heterologous cells including E. coli as well as in vitro assembly of purified capsid proteins has been observed, e.g. in the case of HBV (Birnbaum & Nassal, 1990 ) and of several retroviruses (Campbell & Vogt, 1995) . Since formation or release of virus-like particles and assembly of detectable structures intracellularly or in vitro has not been reported upon expression of the HCV core protein, we attempted to analyse whether core proteins or segments thereof can interact with themselves and to map putative interaction domains within HCV core. To address this question, we took two approaches : (i) the yeast two-hybrid system to detect and map core-core interactions genetically (Fields & Song, 1989 ; Luban et al., 1992) ; (ii) binding of in vitro translated proteins to immobilized specific and nonspecific proteins to analyse interactions biochemically. Our results show that a primary interaction domain resides in the central segment of HCV core but may be masked in the context of the full-length protein and revealed only under certain experimental conditions. These studies are in agreement with and extend a recent report (Matsumoto et al., 1996) which was published during preparation of this manuscript and indicated that the first 115 aa of HCV core are mainly responsible for homomeric interaction.
No interaction of full-length core proteins either containing or lacking the hydrophobic sequence for translocation of E1 was detected in the yeast two-hybrid system. This lack of interaction was not caused by protein instability since the respective fusion proteins could be detected when the second generation yeast shuttle vectors yielding higher protein expression were used. Serial deletions of the C-terminal part of core revealed an interaction domain which was mapped to the region aa 82-102 (main homotypic interaction domain ; Fig. 5) , with some contribution from neighbouring residues. Deletions beyond residue 82, removing part or all of the adjacent basic hydrophilic region (Fig. 5) , led to gradual loss of interacting capacity. Although present in the full-length protein, the main interaction domain was not functional in this context. Fusion of a heterologous sequence (encoded by the j1 reading frame) to the N-terminal part of core did not interfere with its interaction capacity indicating that the masking effect was specific for the remaining part of core and not caused by the requirement for a free C terminus. This masking effect of the Cterminal region (aa 122-172 of core) may be caused by direct binding to the main interaction domain. Accordingly, analysis of core122-172 in the yeast two-hybrid system yielded no homotypic interaction but significant heterotypic interaction with C-terminally truncated core proteins. This region was therefore termed the weak heterotypic interaction domain (Fig.  5) . Taken together, two separate regions for protein interaction were mapped in the HCV core protein : the main homotypic domain consists of a highly conserved sequence rich in tryptophan, proline and glycine residues between aa 73-108 of core (Bukh et al., 1994) . It also contains a phosphorylation site at serine 99. This region is a likely candidate for an essential assembly domain. The second region maps to the hydrophobic C-terminal part of core (Fig. 5) and may be capable of masking the main interaction domain in cis in the context of the full-length protein. This observation suggests that different conformations of HCV core may exist to perform the various functions of this protein. Depending on the accessibility of the protein interaction domain, which may also be determined by the host, these proteins may be capable or incapable of assembling an HCV capsid-like structure.
The main homotypic interaction domain alone (e.g. aa 82-102) did not show any interaction capacity when fused to the GAL4 activation domain. This lack of interaction may be due to aberrant folding of the fusion protein or to steric hindrance because of removal of intervening sequences. Alternatively, N-terminal segments of core may influence its binding capacity. Future studies will analyse whether peptides corresponding to this sequence can bind HCV core in vitro or inhibit core interaction. Fusion of the same part of core to the GAL4 DNA-binding domain yielded trans-activation of β-gal expression even in the absence of a second construct. This result suggests that the main interaction domain may interact with cellular proteins of the transcription machinery if targeted to a specific DNA sequence by its fusion partner. This finding is of some interest considering several recent reports showing that HCV core can trans-activate or suppress transcription from cellular and viral promotors (Ray et al., 1995 ; Shih et al., 1994 Shih et al., , 1995 .
Incubation of in vitro translated core proteins with immobilized core102 or with a nonspecific protein showed that all core proteins tested (including full-length core) bound to core102 with no significant difference in affinity. Binding to the empty resin or to a nonspecific protein was weaker but detectable in most instances and was virtually indistinguishable for the C-terminal hydrophobic segment encoded by construct C12. This observation was in marked contrast to our findings in the two-hybrid system, where core proteins C1 and C2 did not show any interaction with core102. A similar result was reported by Matsumoto et al. (1996) who suggested that the hydrophobic C terminus of core may associate with intracellular membranes within the yeast cell, thereby preventing the GAL4 fusion proteins from entering the nucleus. Our results show, however, that removal of the strongly hydrophobic C-terminal ' signal peptide ' does not rescue interaction capacity. Moreover, fusion proteins containing only the Cterminal hydrophobic domain of core were capable of interacting with the main interaction domain, indicating that these fusion proteins were efficiently transported to the nucleus. It appears unlikely, therefore, that lack of nuclear transport or occlusion of the GAL4-derived fusion domain can explain the observed phenotype in yeast. Nuclear transport of fused and unfused core proteins has also been observed following expression in mammalian cells. While nuclear entry was more obvious for C-terminally truncated proteins (Suzuki et al., 1995 ; Chang et al., 1994 ; Shih et al., 1993 Shih et al., , 1995 , fulllength core was also observed in the nucleus, albeit only at later times after transfection (Shih et al., 1995) and in a small population of transfected cells (Chang et al., 1994) . These observations suggest that alternative conformations of core may also exist in the virus-infected cell which can specify subcellular localization of the protein and may provide the basis for its multiple functions. Alternative core conformations are also suggested by the different binding of monoclonal antibodies directed against conformational epitopes to nuclear and cytoplasmic HCV core proteins. Conceivably, only one of the alternative core conformations permits assembly of viral capsids and may be dependent both on the host cell and the virus isolate. Based on our results, we speculate that one function of the putative host cell factors may be to unmask the main interaction domain in the central part of HCV core. This could occur by releasing the C-terminal interacting region which can subsequently bind to cellular membranes or to cellular or viral interacting proteins (e.g. the viral glycoproteins). Bacterially expressed core102, on the other hand, had been completely unfolded in the process of purification and immobilization and may therefore present additional binding regions. Future experiments will analyse the folding potential and three-dimensional structure of untagged core proteins in order to provide a structural basis for the suggested alternative conformations of this multifunctional protein.
